Sentinel Pension Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Buy
1,767
+161
+10% +$34.6K 0.06% 96
2026
Q1
$349K Buy
1,606
+7
+0.4% +$1.55K 0.05% 107
2025
Q4
$365K Buy
1,599
+83
+5% +$18.9K 0.06% 103
2025
Q3
$351K Buy
1,516
+80
+6% +$16.3K 0.06% 95
2025
Q2
$267K Buy
1,436
+250
+21% +$46.5K 0.04% 102
2025
Q1
$249K Buy
1,186
+12
+1% +$2.33K 0.05% 99
2024
Q4
$209K Buy
1,174
+6
+0.5% +$1.1K 0.04% 108
2024
Q3
$231K Buy
+1,168
New +$218K 0.04% 102
2024
Q2
Sell
-1,259
Closed -$229K 111
2024
Q1
$229K Buy
+1,259
New +$217K 0.05% 96

Other funds holding ABBV

Sentinel Pension Advisors's ABBV Position: Q2 2026 in Review

Sentinel Pension Advisors increased its AbbVie (ABBV) stake by 10% in Q2 2026, buying an estimated $34.6K and bringing the position to 1,767 shares worth $450K. The position accounts for 0.06% of the portfolio, ranked #96.

Sentinel Pension Advisors first reported a position in ABBV in Q1 2024 and has held it in 9 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Sentinel Pension Advisors held 1,767 shares of AbbVie worth $450K as of Q2 2026.
  • Sentinel Pension Advisors bought 161 AbbVie shares in Q2 2026, an estimated $34.6K.
  • AbbVie made up 0.06% of Sentinel Pension Advisors's portfolio in Q2 2026, its #96 holding.
  • Sentinel Pension Advisors first reported a position in AbbVie in Q1 2024 and has held it in 9 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Sentinel Pension Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.